Injectable Drug Delivery is an industry focused on two overarching topics the development of the device & the interaction between drug product and device. The 2025
Injectable Drug Delivery conference brings together a complete big pharma speaker line-up providing technical updates on the relationship between drug product formulation and the device primary packaging, with considerations for formulation strategies, extractables & leachables and toxicological testing of injectable devices.
This conference brings case studies from senior big pharma representatives providing an opportunity to discuss formulation considerations in depth for parenteral packaging, this is the perfect opportunity to benchmark your drug delivery programme and optimise the development of your injectable portfolio.
Why you should attend:
- ENGAGE in discussions on the latest innovations within complex formulations including long acting and large volume injectables with leaders from Novartis, Pfizer, and Medincell.
- GAIN insights from senior industry experts on combination product design considerations including primary packaging material choices and risk management strategies.
- UNCOVER the robust E&L and toxicology testing strategies being employed to minimize unwanted drug-device interactions through detailed case study presentations from CSL Behring, Octapharma and Biophorum.
- DISCUSS the future of sustainable device development with industry leaders from GSK, UCB Pharma, Roche and more, through an interactive panel discussion session.
- BUILD your ecosystem within Injectable Drug Delivery to uncover potential collaborators and keep pace with this rapidly advancing field.
Who should attend:
- Any company striving to optimize injectable delivery of therapies to patients in need.
- If you or your company are working on or looking to break into any of the following areas, this conference is a must!
- Combination product/parenteral drug research and development
- Vaccine R&D
- Combination product formulation
- Primary packaging and container closure integrity challenges
- Biocompatibility, extractables and leachables and toxicology testing
- Device design for advanced modalities
- Regulatory compliance for combination products
Featured Speakers
- Alicja Sobantka, Head of Corporate Material Qualification, Octapharma
- Chantal Pfaffen, Global Lead Material Qualification, CSL Behring
- Christian Proff, Senior Verification Engineer, Roche
- Clovis Pichon, Head of Device Program Leadership, UCB
- Confirmed Senior Representative, Biophorum
- Conor O'Neill, Head of Packaging Development and Design, GSK
- Elodie Hablot, Senior Packaging Engineer, Roche
- Estefania Dos Anjos, Senior Product Specialist, TÜV SÜD
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Jehanzeb Ahmed, Project Leader, Device Engineering, GSK
- Joel Richard, Chief Development Officer, Enterome
- Kai Zwingenberger, Medical Director Global Quality, Akamema Consulting
- Klaus Boje, Senior Scientist Primary Packaging Development, Boehringer Ingelheim
- Marion Briggs, Circular Economy Expert and Member, Alliance to Zero
- Nicola Bettini, Principal Medical Device Manufacturing Engineer, Roche
- Ryan Noble, Associate Director Regulatory Affairs - CMC Devices, GSK
- Simon Dell, Device Development Lead, Pfizer
- Soroosh Bagheriasl, Phorum Director, BioPhorum
- Stephanie Greco, Section Head in Formulation and Process Development, Sanofi
- Sylvestre Grizot, Research & Innovation Leader, MedinCell
- Tony Haythornthwaite, Device Engineering Manager, GSK
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Hilton London Kensington
179-199 Holland Park Ave, Kensington, W11 4UL
London, UK
